Published in Br J Cancer on May 12, 2009
Equol: history, chemistry, and formation. J Nutr (2010) 1.56
Association between dietary inflammatory index and prostate cancer among Italian men. Br J Nutr (2014) 1.04
Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones. Cancer Epidemiol Biomarkers Prev (2010) 0.93
Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits. Am J Clin Nutr (2014) 0.92
Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor. Asian J Androl (2010) 0.90
Emerging research on equol and cancer. J Nutr (2010) 0.90
Estrogens and prostate cancer: etiology, mediators, prevention, and management. Endocrinol Metab Clin North Am (2011) 0.88
The strategies to control prostate cancer by chemoprevention approaches. Mutat Res (2014) 0.87
Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition. Int J Cancer (2012) 0.84
Assessment of information to substantiate a health claim on the prevention of prostate cancer by lignans. Nutrients (2010) 0.81
Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults. J Nutr (2013) 0.81
Chemoprevention of prostate cancer with nutrients and supplements. Cancer Manag Res (2011) 0.81
Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC. Cancer Causes Control (2012) 0.79
Plasma enterolactone and breast cancer risk in the Nurses' Health Study II. Breast Cancer Res Treat (2013) 0.79
Isoflavones and Prostate Cancer: A Review of Some Critical Issues. Chin Med J (Engl) (2016) 0.79
Biomarkers of Dietary Polyphenols in Cancer Studies: Current Evidence and Beyond. Oxid Med Cell Longev (2015) 0.79
The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells. J Steroid Biochem Mol Biol (2011) 0.78
Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies. World J Surg Oncol (2015) 0.76
Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China. Nutr Res (2016) 0.75
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr (2002) 3.14
A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res (1989) 2.18
Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci (2004) 1.92
Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull (2001) 1.90
Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev (2007) 1.85
Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr (2004) 1.41
Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States) Cancer Causes Control (1998) 1.32
A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control (2004) 1.28
Bioavailability of phyto-oestrogens. Br J Nutr (2003) 1.28
Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis (2007) 1.17
Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci (2004) 1.16
Phyto-oestrogens: where are we now? Br J Nutr (1998) 1.16
Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses (2006) 1.11
Physical activity and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer (2007) 1.07
Steroid hormones and carcinogenesis of the prostate: the role of estrogens. Differentiation (2007) 1.06
Daidzein and genistein content of fruits and nuts. J Nutr Biochem (2000) 1.03
Variations in plasma phytoestrogen concentrations in European adults. J Nutr (2007) 1.01
Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. Nutr Cancer (2007) 1.01
Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate (2000) 1.00
Daidzein and genistein contents of vegetables. Br J Nutr (2000) 0.99
Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk. Nutr Cancer (2006) 0.98
Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2002) 0.96
Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev (2008) 0.93
Daidzein and genistein content of cereals. Eur J Clin Nutr (2002) 0.91
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer (2002) 0.90
High throughput quantification of phytoestrogens in human urine and serum using liquid chromatography/tandem mass spectrometry (LC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.89
Role of mammalian lignans in the prevention and treatment of prostate cancer. Nutr Cancer (2005) 0.88
Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control (2004) 0.87
Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev (2003) 0.83
Cohort study of tofu intake and prostate cancer: no apparent association. Cancer Epidemiol Biomarkers Prev (2004) 0.83
Effects of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis (2007) 0.82
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
A physical map of the human genome. Nature (2001) 12.39
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med (1997) 10.62
Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell (1998) 9.85
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer (1999) 9.68
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (2000) 7.66
Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA (1992) 6.56
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05
Comparison of human genetic and sequence-based physical maps. Nature (2001) 4.97
Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol (2001) 4.94
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr (1995) 4.50
Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem (1971) 4.41
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer (1986) 4.11
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
polo encodes a protein kinase homolog required for mitosis in Drosophila. Genes Dev (1991) 3.81
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Coffee and cancer of the pancreas. N Engl J Med (1981) 3.79
Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst (1998) 3.74
Diet and overall survival in elderly people. BMJ (1995) 3.73
Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem (1993) 3.70
Synthesis, deprotection, analysis and purification of RNA and ribozymes. Nucleic Acids Res (1995) 3.59
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr (1994) 3.25
Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25
Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother (1991) 3.18
Lung cancer and passive smoking. Int J Cancer (1981) 3.14
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
Lactation and cancer of the breast. A summary of an international study. Bull World Health Organ (1970) 3.04
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
The A- and B-type cyclins of Drosophila are accumulated and destroyed in temporally distinct events that define separable phases of the G2-M transition. EMBO J (1990) 2.99
Dietary fibre in the British diet. Nature (1978) 2.97
Lactation and reproductive histories of breast cancer patients in greater Athens, 1965-67. Int J Cancer (1969) 2.93
Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond) (2011) 2.93
Coffee, pancreatic cancer and the question of causation. J Epidemiol Community Health (2000) 2.92
Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother (1989) 2.83
Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer (1990) 2.82
History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst (2000) 2.82
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med (1999) 2.79
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75